November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response is based on the Phase 3 DRAGON interim…
BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of traditional Chinese medicine (TCM) for centuries, has actively…
MrMed, India’s largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens the…
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…
In a significant stride towards affordable healthcare, Medkart Pharmacy has unveiled India's first comprehensive online platform dedicated to comparing your…
India's healthcare landscape is undergoing a significant transformation, led by national initiatives like Ayushman Bharat and the Jan Aushadhi Yojana.…
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is…
Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…